🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparative Effects of Sensory Augmentation and Neuromodulation on Enhancing Motor Recovery Among Stroke Survivors

RecruitingNAAges 45 Years - 56 YearsAllLahore University of Biological and Applied Scien…
NCT07266662 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

This study aims to evaluate the effectiveness of two rehabilitation techniques-Sensory Augmentation (using mirror therapy) and Neuromodulation (using transcranial direct current stimulation, tDCS)-in improving motor recovery among stroke survivors. Stroke often results in long-term impairments, particularly in upper limb motor function, which is critical for daily activities. Although current rehabilitation strategies help, more effective solutions are needed to enhance recovery. Participants, aged 45-65 with chronic stroke and upper extremity impairments, will be randomized into three groups: Group 1 will receive a combination of sensory augmentation (mirror therapy) and neuromodulation (tDCS) with routine physical therapy; Group 2 will receive sensory augmentation (mirror therapy) with routine physical therapy; and Group 3 will receive neuromodulation (tDCS) with routine physical thera

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age: 45-65 * Gender: both male and female * Ischemic stroke * Diagnosed cases of middle cerebral artery stroke by neurologist * Stage of recovery - Chronic (more than 6 months) * Burnstromm recovery stage 3 * Good Compliance Exclusion Criteria: * Vestibular Dysfunction * Serious cognitive impairment, * Severe vision or visuospatial neglect * Spasticity (Modified Ashworth scale \>3) * Upper extremity contractures * Upper extremity fractures * Orthopedic disease * Neurological conditions (other than stroke) * Recurrence of stroke or epilepsy during the study period * Serious systemic impairment or concomitant diseases * Patients refused to participate in the experiment
💊

What it tests

  • Sensory Augmentation
  • Neuromodulation
  • Combination of Sensory Augmentation and Neuromodulation
📍

Where

2 sites
Lahore University of Biological and Applied Sciences
Lahore, Pakistan
Pakistan Society of Rehabilitation and Differently Abled Hospital
Lahore, Pakistan
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy